Description
Anti-ageing day cream with SPF 30
This clinically proven formulation blends a powerful combination of ingredients, including Padina Pavonica and Ginkgo Biloba, shown to reduce the appearance of fine lines and wrinkles in 14 days*.
“You will see results. The end. Shortest review in the world!”
– India Knight. The Sunday Times Style, 2017.
Lesley Thomas, Beauty Editor of The Times Magazine, named this her SPF Moisturiser that she swears by in her “25 Best Summer Products”
Our bestselling anti-wrinkle cream has now been formulated with a revolutionary blend of sunscreen to offer superior broad spectrum protection.
This clinically proven formulation blends a powerful combination of ingredients, including Padina Pavonica and Ginkgo Biloba, shown to reduce the appearance of fine lines and wrinkles in 14 days*. With hydration increased, elasticity and suppleness appear improved and the skin looks firm and toned.
A next generation micronized sunscreen offers a unique encapsulated blend that leaves no white streaks on the face and offers evenly distributed broad spectrum UVA and UVB protection without compromise to the texture of the cream.
This is the ultimate anti-ageing cream from ELEMIS.
APPLICATION STEPS
Apply every morning to cleansed, dry skin.
For maximum benefit, use after Pro-Collagen Quartz Lift Serum.
THERAPIST TIP
Always use upward stroking sweeping motions when applying moisturiser to the face.
ABOUT THE BRAND
ELEMIS was born out of the vision to bring together the power of nature, science and aromatics. To harness the dynamism of the highest-grade actives and create a skincare line that would transform the frontline of the beauty industry.
ELEMIS begins with the earth’s natural resources. Powerful marine and plant actives coupled with intricately-blended aromatics form the foundation of all our products. We ethically source and extract, harnessing and boosting remarkable natural properties through technology. ELEMIS is where the science of nature meets the science of skin.
Reviews
There are no reviews yet.